Cargando…

Phase I, two-way, crossover study to demonstrate bioequivalence and to compare safety and tolerability of single-dose XM17 vs Gonal-f(®) in healthy women after follicle-stimulating hormone downregulation

BACKGROUND: XM17 is a recombinant human follicle-stimulating hormone (rhFSH) intended mainly for use in controlled ovarian hyperstimulation and the treatment of anovulation. The purpose of the current study was to establish bioequivalence, safety and tolerability of single 300-IU subcutaneous (sc) d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lammerich, Andreas, Mueller, Arnd, Bias, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665917/ https://www.ncbi.nlm.nih.gov/pubmed/26621118 http://dx.doi.org/10.1186/s12958-015-0124-y

Ejemplares similares

Manufacturing of Recombinant Human Follicle-Stimulating Hormone Ovaleap(®) (XM17), Comparability with Gonal-f(®), and Performance/Consistency
por: Winstel, Rainer, et al.
Publicado: (2017)

Phase 1 safety, tolerability, and pharmacokinetic study of single ascending doses of XM17 (recombinant human follicle-stimulating hormone) in downregulated healthy women
por: Lammerich, Andreas, et al.
Publicado: (2015)

Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART)
por: Strowitzki, Thomas, et al.
Publicado: (2016)

Olivetti OPE XM 5220/2
Publicado: (2017)

A randomized, double-blind, active control, multicenter, dose-finding study of lipegfilgrastim (XM22) in breast cancer patients receiving myelosuppressive therapy
por: Buchner, Anton, et al.
Publicado: (2014)

Safety and efficacy of Ovaleap® (recombinant human follicle-stimulating hormone) for up to 3 cycles in infertile women using assisted reproductive technology: a phase 3 open-label follow-up to Main Study
por: Strowitzki, Thomas, et al.
Publicado: (2016)

Involvement of the capsular GalXM-induced IL-17 cytokine in the control of Cryptococcus neoformans infection
por: LaRocque-de-Freitas, Isabel Ferreira, et al.
Publicado: (2018)

Efficacy, safety, and immunogenicity of a biosimilar recombinant human follicle-stimulating hormone (Folitime(®)) vs. Gonal-f(®) in women undergoing ovarian stimulation for IVF: A randomized, multicenter, evaluator-blinded, non-inferiority study
por: Pasqualini, Agustín, et al.
Publicado: (2021)

Tetragonal polymorph of 5,5-dichlorobarbituric acid
por: Gelbrich, Thomas, et al.
Publicado: (2011)

In-vivo biological activity and glycosylation analysis of a biosimilar recombinant human follicle-stimulating hormone product (Bemfola) compared with its reference medicinal product (GONAL-f)
por: Mastrangeli, Renato, et al.
Publicado: (2017)

Perfect k-Colored Matchings and [Formula: see text] -Gonal Tilings
por: Aichholzer, Oswin, et al.
Publicado: (2018)

Pharmacokinetics and Bioequivalence of Fudosteine in Healthy Chinese Volunteers Under Fasting and Fed Conditions: A 4‐Way Replicate Crossover Study
por: Zhu, Mingxue, et al.
Publicado: (2022)

AN INHERITED X-LINKED SERUM SYSTEM IN MAN : THE XM SYSTEM
por: Berg, Kåre, et al.
Publicado: (1966)

A four-dimensional model for the Ba–Ti–O dodecagonal quasicrystal
por: Yamada, Tsunetomo
Publicado: (2022)

Bioequivalence of HTX-019 (aprepitant IV) and fosaprepitant in healthy subjects: a Phase I, open-label, randomized, two-way crossover evaluation
por: Ottoboni, Tom, et al.
Publicado: (2018)

Comparison of pharmacokinetic and safety profiles between Bemfola(®) and Gonal-f(®) after subcutaneous application
por: Wolzt, Michael, et al.
Publicado: (2015)

A Single‐Dose, Open‐Label, Randomized, Two‐Way Crossover Study in Healthy Japanese Participants to Evaluate the Bioequivalence and the Food Effect on the Pharmacokinetics of Daprodustat
por: Yamada, Masanori, et al.
Publicado: (2020)

Redetermination of the hexagonal struvite analogue Cs[Mg(OH(2))(6)](PO(4))
por: Weil, Matthias
Publicado: (2008)

Pharmacokinetics of oral pridinol: Results of a randomized, crossover bioequivalence trial in healthy subjects
por: Richter, Maren, et al.
Publicado: (2021)

The Bioequivalence of Two Peficitinib Formulations, and the Effect of Food on the Pharmacokinetics of Peficitinib: Two‐Way Crossover Studies of a Single Dose of 150 mg Peficitinib in Healthy Volunteers
por: Shibata, Mai, et al.
Publicado: (2020)

Structure of Vibrio Phage XM1, a Simple Contractile DNA Injection Machine
por: Wang, Zhiqing, et al.
Publicado: (2023)

A tetragonal polymorph of bis[hydrotris(pyrazol-1-yl)borato]iron(II)
por: Ni, Zhong-Hai, et al.
Publicado: (2011)

Pharmacokinetics and bioequivalence of sunitinib and Sutent(®) in Chinese healthy subjects: an open-label, randomized, crossover study
por: Wang, Yanli, et al.
Publicado: (2023)

Size-reduced fexuprazan 20 mg demonstrated the optimal bioavailability and bioequivalence with the reference formulation
por: Yang, A-Young, et al.
Publicado: (2023)

A Randomized, Open-Label, Two-Way Crossover, Single-Dose Bioequivalence Study of Temozolomide 200 mg/m(2) (Dralitem(®) vs. Temodal(®) Capsules) in Patients with Primary Tumors of the Central Nervous System Under Fasting Conditions
por: Muggeri, Alejandro, et al.
Publicado: (2017)

Randomized, double-blind, two-way crossover bioequivalence and adhesion study, in healthy women, of a transdermal contraceptive patch with a newly sourced adhesive component at the end of shelf life vs. the EVRA patch at the beginning of shelf life
por: Sanga, Madhu, et al.
Publicado: (2022)

Mobilization of PBSC for allogeneic transplantation by the use of the G-CSF biosimilar XM02 in healthy donors
por: Schmitt, M, et al.
Publicado: (2013)

Crystal structure of the tetragonal polymorph of bis(1-ethyl-3-methylimidazolium) tetrabromidocadmate
por: Đorđević, Tamara, et al.
Publicado: (2016)

Comparing a biosimilar follitropin alfa (Cinnal-fⓇ) with Gonal-fⓇ in women undergoing ovarian stimulation: An RCT
por: Hossein Rashidi, Batool, et al.
Publicado: (2021)

Single-Dose, Randomized, Open-Label, Two-Way, Crossover Bioequivalence Study of Two Formulations of Pregabalin 300 mg Hard Capsules in Healthy Volunteers Under Fasting Conditions
por: Filipe, Augusto, et al.
Publicado: (2015)

Pharmacokinetics and Bioequivalence of Two Formulations of Febuxostat 40-Mg and 80-Mg Tablets: A Randomized, Open-Label, 4-Way Crossover Study in Healthy Chinese Male Volunteers
por: Luo, Zhu, et al.
Publicado: (2016)

Chinese- and French-Manufactured Immediate-Release Glucophage(®) Bioequivalence: A Randomized, Open-Label, Crossover Study
por: Hu, Chaoying, et al.
Publicado: (2022)

Draft Genome Sequence of Loktanella cinnabarina Strain XM1 Isolated from Coastal Surface Water
por: Ma, Ruijie, et al.
Publicado: (2017)

Bioequivalence and Pharmacokinetic Evaluation of Two Formulations of Risperidone 2 mg: An Open-Label, Single-Dose, Fasting, Randomized-Sequence, Two-Way Crossover Study in Healthy Male Chinese Volunteers
por: Liu, Yun, et al.
Publicado: (2012)

Three-way, three-period, crossover bioequivalence study of single oral dose of three brands of 300 mg phenytoin sodium tablets marketed in India, on healthy Indian human volunteers
por: Doshi, Maulik S., et al.
Publicado: (2013)

Bioequivalence of Generic and Brand Name Clozapine in Korean Schizophrenic Patients: A Randomized, Two-Period, Crossover Study
por: Woo, Young Sup, et al.
Publicado: (2015)

Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial
por: Alloway, Rita R., et al.
Publicado: (2017)

A Single-Dose, Crossover-Design Bioequivalence Study Comparing Two Nicotine Gum Formulations in Healthy Subjects
por: Du, Daniel
Publicado: (2018)

Levocetirizine Oral Disintegrating Tablet: A Randomized Open‐Label Crossover Bioequivalence Study in Healthy Japanese Volunteers
por: Ino, Hiroko, et al.
Publicado: (2020)

Pharmacokinetics, bioavailability, and bioequivalence of lower‐sodium oxybate in healthy participants in two open‐label, randomized, crossover studies
por: Chen, Cuiping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_95un6buq7kq4aolapk9dcmksq6